Glucerna Ready-to-Drink

GLUCERNA READY-TO-DRINK

Glucerna® Ready-to-Drink Vanilla flavor 220mL^▲

MOST CLINICALLY PROVEN DIABETES NUTRITION BRAND IN THE WORLD^△

Advanced, complex, slowly digested, carbohydrate blend with low GI ingredients^ (including dual fiber blend) to help manage blood sugar
Helps promote the secretion of GLP-1 to improve insulin secretion¹, helps lower postprandial glucose response^2,3 and HbA1c⁴
Contains 4x myo-inositol† to help improve insulin sensitivity^#,5-7
Complete, balanced nutrition with 20 vitamins & minerals and low sugar, low-GI* formulation
Nutrition profile meets recommendations of ADA***

IMPORTED FROM THE NETHERLANDS

Water, maltodextrin, sucromalt, VEGETABLE OIL (canola oil, high oleic sunflower oil, corn oil), CASEINATES (sodium caseinate, calcium caseinate), soy protein isolate, glycerine, MINERALS (potassium citrate, potassium chloride, calcium carbonate, calcium citrate, magnesium phosphate dibasic, sodium chloride, calcium phosphate tribasic, sodium citrate, magnesium chloride, potassium phosphate dibasic, zinc sulfate, ferrous sulfate, manganese sulfate, cupric sulfate, chromium chloride, sodium molybdate, potassium iodide, sodium selenite), fructo-oligosaccharides, myo-inositol, flavoring, oat fiber, emulsifier (soy lecithin), stabilizer (cellulose), stabilizer (carrageenan), stabilizer (sodium carboxymethyl cellulose), stabilizer (gellan gum), choline chloride, VITAMINS (ascorbic acid, Vitamin E, niacinamide, calcium pantothenate, thiamin hydrochloride, pyridoxine hydrochloride, riboflavin, Vitamin A palmitate, folic acid, phylloquinone, biotin, Vitamin D₃, cyanocobalamin), sweetener (acesulfame potassium), sweetener (sucralose), taurine, L-carnitine, color (E100).

Contains milk and soy ingredients.

Nutrition Information	Unit	Per 100ml	Per Serving Per 220ml		Unit	Per 100ml	Per Serving Per 220ml
Energy	kcal	96	212	Vitamin B₆	mg	0.21	0.46
Protein	g	4.62	10.16	Vitamin B₁₂	µg	0.32	0.70
Fat	g	3.74	8.23	Niacin equivalents	mg NE	1.6	3.5
Monounsaturated fatty acids	g	2.1	4.6	Pantothenic acid	mg	0.64	1.4
Polyunsaturated fatty acids	g	1.0	2.2	Biotin	µg	3.2	7.0
Saturated fatty acids	g	0.40	0.88	MINERALS
Trans fat	g	0	0	Sodium	mg	95	209
Cholesterol	mg	0	0	Potassium	mg	128	282
Carbohydrate	g	10.03	22.07	Chloride	mg	110	242
Polyols	g	1.05	2.31	Calcium	mg	81	178
Sugars	g	2.40	5.28	Phosphorus	mg	56	123
Fiber	g	2.05	4.51	Magnesium	mg	17	37
Soluble fiber	g	1.82	4.00	Iron	mg	0.96	2.1
Oligofructose (FOS)	g	0.46	1.01	Zinc	mg	1.2	2.6
Insoluble fiber	g	0.23	0.51	Manganese	mg	0.27	0.59
Taurine	mg	7.3	16	Copper	µg	112	246
Carnitine	mg	6.4	14	Iodine	µg	12.8	28
Inositol	mg	292	642	Selenium	µg	5.6	12
Choline	mg	37	81	Chromium	µg	14.4	32
VITAMINS				Molybdenum	µg	9.6	21
Vitamin A	µg RE	71	156	OTHER CHARACTERISTICS
Vitamin D₃	µg	3.0	6.6	Osmolality	mOsm/kgH₂O	530
Vitamin E	mg α-TE	1.92	4.2	kcal/N (Non-protein kcal/N) ratio	131:1 (106:1)
Vitamin K₁	µg	7.2	16	Renal Solute Load	mOsm/L	382
Vitamin C	mg	8.0	18	Gluten free	Yes
Folic acid	µg	29	64	Suitable for individuals with lactose sensitivity/intolerance
Vitamin B₁	mg	0.15	0.33
Vitamin B₂	mg	0.16	0.35

RELATED PRODUCTS

VIEW ALL

Article

Glucerna Tube Feed

Most clinically proven diabetes nutrition brand in the world

Article

Osmolite HN

High nitrogen, complete and balanced isotonic liquid nutrition for tube feeding

Article

Jevity

Complete and balanced isotonic liquid nutrition with fibre for tube feeding

Examining guidelines and new evidence in oncology nutrition

Logo
Main Image
Tagname: Article
Logo link
title: Examining guidelines and new evidence in oncology nutrition: a position paper on gaps and opportunities in multimodal approaches to improve patient care
Content Reference: /content/an/hcpproconnect/hk/en/home/adult/resources/public/Examining-guidelines-and-new-evidence-in-oncology-nutrition-a-position-paper-on-gaps-and-opportunities-in-multimodal-approaches-to-improve-pati
Abstract: Malnutrition, muscle loss, and cachexia are prevalent in cancer and remain key challenges in oncology today. These conditions are frequently underrecognised and undertreated and have devastating consequences for patients. Early nutrition screening/assessment and intervention are associated with improved patient outcomes.
Publish Date:: Oct 2021

The Benefits of Beta-Hydroxy-Beta-Methylbutyrate (or HMB)

Logo
Main Image
Tagname: ARTICLE
Logo link
title: The Benefits of Beta-Hydroxy-Beta-Methylbutyrate (or HMB)
Content Reference: /content/an/hcpproconnect/hk/en/home/adult/resources/public/hmb-article
Abstract: The benefits of oral nutritional supplements containing HMB are supported by evidence from over 18 clinical studies,^9-27 read this short article to learn more about the benefits of HMB.
Publish Date:

The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition

Logo
Main Image
Tagname: Article
Logo link
title: The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition
Content Reference: /content/an/hcpproconnect/hk/en/home/adult/resources/public/The-Underappreciated-Role-of-Low-Muscle-Mass-in-the-Management-of-Malnutrition
Abstract: This opinion article, published in Journal of American Medical Directors Association (JAMDA), addresses the role of muscle mass in improving health outcomes in a variety of disease states. It also offers strategies you can use to help patients manage low muscle mass and prevent muscle loss.
Publish Date:: Jan 2019

ADULT

GLUCERNA

MYOINOSITOL

ADVANCED COMPLEX CARBOHYDRATE

LOW GI

DIABETICS

COMPLETE & BALANCED NUTRITION

LIQUID

HBA1C

Footnotes:

△ Based on published clinical studies only. Literature search was conducted in Dialog databases and Dimensions full-text searching database in August 2022.

*** American Diabetes Association. Diabetes Care 2023;46(Suppl 1):S68-S96. Meets American Diabetes Association's recommendations for dietary fiber, sodium, monounsaturated fatty acids, polyunsaturated fatty acids, trans fatty acids and saturated fatty acids.

▲ This product is not registered under the Pharmacy and Poisons Ordinance or the Chinese Medicine Ordinance. Any claim made for it has not been subject to evaluation for such registration. This product is not intended to diagnose, treat or prevent any disease. 此產品沒有根據<藥劑業及毒藥條例>或<中醫藥條例>註冊。為此產品作出的任何聲稱亦沒有為進行該等註冊而接受評核。此產品並不供作診斷、治療或預防任何疾病之用。

^ Low glycemic index ingredients include: (for bottle) fibersol-2, sucromalt, FOS and oat fiber.

† New Glucerna contains 337.9mg/100ml (Powder), 292mg/100ml (Bottle); Previous Glucerna contained 84mg/100ml (Powder), 0mg/100ml (Bottle); Compared with previous Glucerna triple care formulation.

#Inositol helps supports insulin sensitivity by promoting GLUT4 translocation thus increasing glucose entry into the cell.

*Sugar 2.4g/100ml, GI=27 (for bottle)

References:

Devitt AA et al., J Diabetes Res Clin Mtab. 2012;1:20
Mottalib et al., Nutrients. 2016 Jul 11;8(7):443
Devitt AA et al., Advances in Bioscience and Biotechnology, 2013, 4, 1-10
Chee SS et al., BMJ Open Diabetes Res Care. 2017;5(1):e000384.
Bevilacqua A, et al. Int J Endocrinol. 2018:1968450
Dang NT, et al. Biosci Biotechnol Biochem. 2010;74(5):1062-1067
Yamashita Y, et al. J agric Food Chem. 2013;61(20):4850-4854

HKG.2025.58198.AND.1

Adult